Genetic and cellular studies highlight that A Disintegrin and Metalloproteinase 19 is a protective biomarker in human prostate cancer

BACKGROUND: Prostate cancer is the second most frequently diagnosed cancer in men worldwide. Current treatments include surgery, androgen ablation and radiation. Introduction of more targeted therapies in prostate cancer, based on a detailed knowledge of the signalling pathways, aims to reduce side...

Descripción completa

Detalles Bibliográficos
Autores principales: Hoyne, Gerard, Rudnicka, Caroline, Sang, Qing-Xiang, Roycik, Mark, Howarth, Sarah, Leedman, Peter, Schlaich, Markus, Candy, Patrick, Matthews, Vance
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766641/
https://www.ncbi.nlm.nih.gov/pubmed/26912236
http://dx.doi.org/10.1186/s12885-016-2178-4

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4766641/
https://www.ncbi.nlm.nih.gov/pubmed/26912236
http://dx.doi.org/10.1186/s12885-016-2178-4

Ejemplares similares